Comera Life Sciences Holdings, Inc. Common Stock
CMRA
CMRA was delisted on the 16th of November, 2023.
10 hedge funds and large institutions have $710K invested in Comera Life Sciences Holdings, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.41% more ownership
Funds ownership: 0% → 1.41% (+1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSAG
Lake Street Advisors Group
Portsmouth,
New Hampshire
|
+$331K |
| 2 |
Jane Street
New York
|
+$145K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$127K |
| 4 |
BCM
Bluefin Capital Management
New York
|
+$91.1K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$72.6K |
Top Sellers
CMRA Hedge Fund Activity: Q2 2022 in Review
10 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Common Stock (CMRA) for Q2 2022, worth a combined $710K.
Buyers outnumbered sellers: 10 funds opened new CMRA positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Lake Street Advisors Group, opening a new position worth an estimated $331K.
- 10 institutional investors held Comera Life Sciences Holdings, Inc. Common Stock (CMRA) as of Q2 2022, up from 0 in Q1 2022.
- Funds reported $710K of Comera Life Sciences Holdings, Inc. Common Stock stock for Q2 2022.
- 10 funds opened new Comera Life Sciences Holdings, Inc. Common Stock positions in Q2 2022 and 0 closed out, a net change of +10 holders.
- The largest Comera Life Sciences Holdings, Inc. Common Stock buyer in Q2 2022 was Lake Street Advisors Group, an estimated $331K added.
Based on aggregated 13F filings for Q2 2022.